SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

C4 Therapeutics Q3'26 EPS Estimate Is $(0.20)

The company is scheduled to report Q3'26 results on October 29; the release time is not specified in the headline, while the body also cites 8:00 a.m. ET (12:00 p.m. UTC).

CCCC

CCCC (C4 Therapeutics, Inc.) is set to announce its Q3'26 results on October 29, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 8.85 million USD with EPS (earnings per share) anticipated at (0.20) USD. Learn more details at…